Arginase Deficiency has emerging NIH research funding with 1 grant totaling $683K.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Arginase Deficiency. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
3 clinical trials registered but no NIH-funded clinical or translational research grants found for arginase deficiency. Trials may be industry-sponsored or funded through non-NIH sources.
7 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for arginase deficiency. Existing research activity suggests this may be a viable area for grant applications.
7 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for arginase deficiency. Existing research activity suggests this may be a viable area for grant applications.
7 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for arginase deficiency. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Arginase Deficiency as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Arginase Deficiency.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.